Bridging to Transplant for HCC
with Dr. Jennifer Berumen and Dr. Isabel Newton
Transplant Surgeon Dr. Jennifer Berumen and Interventional Radiologist Dr. Isabel Newton discuss the treatment of HCC and the importance of multi-specialty collaboration in bridging these patients to successful liver transplantation. Special discussion was given around this HCC consortium article in Annals of Surgery:
Special thanks to our sponsor
BackTable, LLC (Producer). (2020, May 21). Ep. 64 – Bridging to Transplant for HCC [Audio podcast]. Retrieved from
In this Episode
Dr. Jennifer Berumen is a transplant surgeon and assistant professor with the UCSD Department of Surgery in San Diego.
Dr. Isabel Newton is a practicing interventional radiologist at UC San Diego Health in San Diego, CA.
Host Dr. Christopher Beck is a practicing interventional radiologist with Regional Radiology Group in New Orleans.
TriSalus Infusion Systems
TriSalus Life Sciences is dedicated to improving patient outcomes in HCC and other highly intractable solid tumors. TriSalus Infusion Systems have the potential to deliver diagnostic, therapeutic, and immuno-stimulant agents directly into the tumor vascular, powered by their proprietary pressure-enabled delivery approach.
• Milan Criteria:
• NCCN Guidelines:
• Criteria for Liver Transplantation in Hepatocellular Carcinoma:
• The Interventional Initiative:
• Paper discussed:
DiNorcia J, Florman SS, Haydel B, et al. Pathologic Response to Pretransplant Locoregional
Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular
Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium. Ann Surg.
Disclaimer: The Materials available on the BackTable Podcast are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.